Brian Anderson

About the Author Brian Anderson


Aileron Therapeutics (ALRN) Receives a Buy from William Blair

In a report issued on October 19, Matt Phipps from William Blair maintained a Buy rating on Aileron Therapeutics (ALRN). The company’s shares …

Raymond James Believes Avantor (AVTR) Still Has Room to Grow

Raymond James analyst Lawrence Keusch maintained a Buy rating on Avantor (AVTR) today. The company’s shares closed last Friday at $24.

Analysts Have Conflicting Sentiments on These Financial Companies: First Business Financial (FBIZ), First Financial Bancorp (FFBC) and First Horizon (FHN)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on First Business Financial (FBIZ), First Financial …

Needham Assigns a Buy Rating on Phasebio Pharmaceuticals (PHAS)

In a report released today, Chad Messer from Needham assigned a Buy rating to Phasebio Pharmaceuticals (PHAS), with a price target of $18.00.

Goldman Sachs Remains a Buy on UniCredit SpA (UNCFF)

Goldman Sachs analyst Jernej Omahen maintained a Buy rating on UniCredit SpA (UNCFF) today and set a price target of EUR12.30.

Aerie Pharma (AERI) Received its Third Buy in a Row

After Mizuho Securities and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this time from …

Oppenheimer Maintains Their Buy Rating on Chinook Therapeutics (KDNY)

In a report released today, Justin Kim from Oppenheimer maintained a Buy rating on Chinook Therapeutics (KDNY), with a price target of $25.00.

Jefferies Thinks Ardmore Shipping’s Stock is Going to Recover

In a report released today, Randy Giveans from Jefferies maintained a Buy rating on Ardmore Shipping (ASC), with a price target of $6.00.

Jefferies Maintains a Buy Rating on Tsakos Energy (TNP)

Jefferies analyst Randy Giveans maintained a Buy rating on Tsakos Energy (TNP) today and set a price target of $11.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts